Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective

GJ Biessels, F Nobili, CE Teunissen, R Simó… - The Lancet …, 2020 - thelancet.com
People with type 2 diabetes are at an increased risk of cognitive impairment and dementia
(including Alzheimer's disease), as well as subtle forms of cognitive dysfunction. Current …

EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3

E Guedj, A Varrone, R Boellaard, NL Albert… - European journal of …, 2022 - Springer
The present procedural guidelines summarize the current views of the EANM Neuro-
Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …

Brain control of blood glucose levels: implications for the pathogenesis of type 2 diabetes

KM Alonge, DA D'Alessio, MW Schwartz - Diabetologia, 2021 - Springer
Despite a rapidly growing literature, the role played by the brain in both normal glucose
homeostasis and in type 2 diabetes pathogenesis remains poorly understood. In this review …

Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19

R Ferrucci, L Cuffaro, A Capozza, C Rosci… - Journal of …, 2023 - Springer
Emerging evidence indicates that the etiologic agent responsible for coronavirus disease
2019 (COVID-19), can cause neurological complications. COVID-19 may induce cognitive …

Borderline resectable and locally advanced pancreatic cancer: FDG PET/MRI and CT tumor metrics for assessment of pathologic response to neoadjuvant therapy …

A Panda, I Garg, MJ Truty, TL Kline… - American Journal of …, 2021 - Am Roentgen Ray Soc
BACKGROUND. Imaging biomarkers of response to neoadjuvant therapy (NAT) for
pancreatic ductal adenocarcinoma (PDA) are needed to optimize treatment decisions and …

Normal values for 18F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patients

AH Dias, AK Hansen, OL Munk, LC Gormsen - EJNMMI research, 2022 - Springer
Background Dynamic whole-body (D-WB) FDG PET/CT is a recently developed technique
that allows direct reconstruction of multiparametric images of metabolic rate of FDG uptake …

Assessing PET parameters in oncologic 18F-FDG studies

I Sarikaya, A Sarikaya - Journal of nuclear medicine technology, 2020 - Soc Nuclear Med
PET imaging, particularly oncologic applications of 18F-FDG, has become a routine
diagnostic study. To better describe malignancies, various PET parameters are used. In 18F …

68Ga-labeled fibroblast activation protein inhibitor PET/CT for the early and late prediction of pathologic response to neoadjuvant chemotherapy in breast cancer …

L Chen, S Zheng, L Chen, S Xu, K Wu… - Journal of Nuclear …, 2023 - Soc Nuclear Med
68Ga-labeled fibroblast activation protein inhibitor (68Ga-FAPI) PET/CT has demonstrated
promising clinical results, with a higher SUVmax and tumor-to-background ratio (TBR) in …

Influences on PET quantification and interpretation

JMM Rogasch, F Hofheinz, L van Heek, CA Voltin… - Diagnostics, 2022 - mdpi.com
Various factors have been identified that influence quantitative accuracy and image
interpretation in positron emission tomography (PET). Through the continuous introduction …

Prognostic value of fibroblast activation protein expressing tumor volume calculated from [68 Ga]Ga-FAPI PET/CT in patients with esophageal squamous cell …

L Zhao, Y Pang, S Chen, J Chen, Y Li, Y Yu… - European Journal of …, 2023 - Springer
Background This study aimed to investigate the prognostic value of semiquantitative
parameters derived from [68 Ga] Ga-fibroblast activation protein inhibitor (FAPI) PET/CT for …